Recently, Beijing TIROMU Medical Technology Co., Ltd., an ophthalmic intelligent surgical robot company, has completed a Pre-A financing round of tens of millions of RMB.

The round was jointly led by ZGC Capital, a subsidiary of ZGC Group, and Aibo Hongsheng. The funds raised will be mainly used to advance clinical trials and registration filing for TIROMU’s fundus injection surgical robot, accelerate R&D iteration of its general-purpose ophthalmic surgical robot, and support the industrialization and commercialization of related technologies.